I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

Johnson & Johnson is highlighted as an excellent dividend stock choice due to its 64-year streak of consecutive annual dividend increases, making it a Dividend King. With a diversified portfolio spanning Innovative Medicine and MedTech segments, 28 billion-dollar product platforms, and strategic investments in oncology, immunology, and robotic surgery, J&J offers stable, growing cash payouts backed by a resilient healthcare business. The company raised 2026 guidance and continues to innovate while maintaining a ~2% dividend yield.